Why Kymera (KYMR) Could Be One of Biotech’s Most Interesting Growth Stories?
Kymera Therapeutics Inc. (NASDAQ:KYMR) is one of the best high-beta stocks to buy now. The company currently commands an optimistic outlook, ...
Tuesday, May 5, 2026
Tag: Biotechs
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.